Updated:
Columbus Venture Capital
Columbus Venture Capital invests in high-growth technology and life science companies from offices in Denmark, the UK, Spain, and multiple US cities.
Columbus Venture Capital
Columbus Venture Capital invests in high-growth technology and life science companies from offices in Denmark, the UK, Spain, and multiple US cities. It targets deep tech, life sciences, and enterprise software across venture capital stages. Portfolio holdings include Nuevolution and a US-based drug developer from 2020. Team size and assets under management are not publicly disclosed. The firm raises funds from institutional investors, and its governance and succession structure remain opaque due to limited public disclosures.
General information
Firm type
Venture Capital
Location
Region
Europe
Country
Denmark
City
Valencia
Corporate office
Copenhagen, Denmark
Additional offices
London, United Kingdom · Pasadena, United States · Lincoln, United States · Alexandria, United States · Boston, United States · Donostia-San Sebastian, Spain
Sector focus
Frequently asked questions
Who runs investment decisions at Columbus Venture Capital?
The firm's investment leadership is not publicly disclosed. Public records do not name specific managing partners or CIOs for Columbus Venture Capital as of 2026.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: